{"id":356987,"date":"2026-11-20T10:24:15","date_gmt":"2026-11-20T04:54:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=356987"},"modified":"2026-11-20T10:24:15","modified_gmt":"2026-11-20T04:54:15","slug":"why-accretion-nutraveda-share-price-fall-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/","title":{"rendered":"Accretion Nutraveda (ANL) Share Price Falls 12.11% in Latest Session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/anl\/accretion-nutraveda-ltd-share-price-today\">Accretion Nutraveda (ANL)<\/a> share price fell to Rs 296.2 today, down 12.11% from the previous close. Market cap was Rs 243.99 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Accretion Nutraveda Share Price fell sharply to Rs 296.20, down 12.11% from the previous close of Rs 337, while market capitalisation stood at Rs 243.99 crore. The move keeps Accretion Nutraveda Share Price in focus for readers tracking stock market today action in the Healthcare sector, especially because the decline came without a company-specific catalyst that can be established from the available figures. Univest data confirms the move itself, though no company-specific trigger has been identified. The latest Univest figures also place the company in the Micro Cap category, which matters for context because price moves in this segment can appear larger in percentage terms even when the absolute rupee move is measured against a modest market value.<\/p>\n<p>For anyone following Accretion Nutraveda Share Price Today, the stock opened at Rs 296.20, touched a high of Rs 296.20 and a low of Rs 296.20, which shows that the entire move was captured at one printed level in the current session so far. The focus now shifts from the headline decline to what the valuation and profitability metrics say about the business. Univest tracks these numbers together so investors can read the price move alongside fundamentals rather than in isolation.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Accretion_Nutraveda_ANL_Share_Price_Today_Price_Action_Analysis\" title=\"Accretion Nutraveda (ANL) Share Price Today: Price Action Analysis\">Accretion Nutraveda (ANL) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Accretion_Nutraveda_ANL_Fundamental_Analysis\" title=\"Accretion Nutraveda (ANL) Fundamental Analysis\">Accretion Nutraveda (ANL) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Why_Investors_Are_Watching_Accretion_Nutraveda\" title=\"Why Investors Are Watching Accretion Nutraveda\">Why Investors Are Watching Accretion Nutraveda<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#About_Accretion_Nutraveda\" title=\"About Accretion Nutraveda\">About Accretion Nutraveda<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Track_Accretion_Nutraveda_Share_Price_on_Univest\" title=\"Track Accretion Nutraveda Share Price on Univest\">Track Accretion Nutraveda Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Why_did_Accretion_Nutraveda_Share_Price_fall_today\" title=\"Why did Accretion Nutraveda Share Price fall today?\">Why did Accretion Nutraveda Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#What_is_Accretion_Nutraveda_Share_Price_today\" title=\"What is Accretion Nutraveda Share Price today?\">What is Accretion Nutraveda Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#What_is_Accretion_Nutraveda_market_capitalisation\" title=\"What is Accretion Nutraveda market capitalisation?\">What is Accretion Nutraveda market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#How_does_Accretion_Nutraveda_Share_Price_compare_with_the_healthcare_benchmark\" title=\"How does Accretion Nutraveda Share Price compare with the healthcare benchmark?\">How does Accretion Nutraveda Share Price compare with the healthcare benchmark?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Is_Accretion_Nutraveda_Share_Price_expensive_versus_peers\" title=\"Is Accretion Nutraveda Share Price expensive versus peers?\">Is Accretion Nutraveda Share Price expensive versus peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#What_do_EPS_and_book_value_mean_for_Accretion_Nutraveda_Share_Price\" title=\"What do EPS and book value mean for Accretion Nutraveda Share Price?\">What do EPS and book value mean for Accretion Nutraveda Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#Does_Accretion_Nutraveda_pay_a_dividend\" title=\"Does Accretion Nutraveda pay a dividend?\">Does Accretion Nutraveda pay a dividend?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#What_are_the_key_return_ratios_for_Accretion_Nutraveda\" title=\"What are the key return ratios for Accretion Nutraveda?\">What are the key return ratios for Accretion Nutraveda?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-accretion-nutraveda-share-price-fall-today-2026\/#What_should_investors_watch_next_in_Accretion_Nutraveda_Share_Price\" title=\"What should investors watch next in Accretion Nutraveda Share Price?\">What should investors watch next in Accretion Nutraveda Share Price?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_ANL_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Accretion Nutraveda (ANL) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 296.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 337<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 40.80 (-12.11%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 296.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 296.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 296.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 243.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Micro Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Accretion Nutraveda Share Price Today shows a clear one-session decline of Rs 40.80 from the previous close of Rs 337, or 12.11%. The current price is Rs 296.20, and the day open, day high and day low are all Rs 296.20, which means the stock has traded at the same level recorded in this update. For readers scanning Accretion Nutraveda Share Price Live, this is a straightforward price fall rather than a broad range-bound move. The company\u2019s market capitalisation of Rs 243.99 crore places it in the Micro Cap category, and that size context matters when reading Accretion Nutraveda Share Price because smaller companies often show sharp percentage swings on price movement. Accretion Nutraveda Share Price Today therefore reflects a marked re-pricing in the latest session, and the next analytical step is to check whether the underlying fundamentals justify the current level.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Accretion_Nutraveda_ANL_Fundamental_Analysis\"><\/span><strong>Accretion Nutraveda (ANL) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 243.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.14x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 43.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Accretion Nutraveda (ANL) fundamental metrics show P\/E 48.14x, P\/B 7.73x, ROE 27.68%, ROCE 30.19%. Read together, these ratios describe the company&#8217;s position rather than a recommendation.<\/p>\n<p>Accretion Nutraveda has a market capitalisation of Rs 243.99 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 48.14x, P\/B at 7.73x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.68% and ROCE of 30.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 7, book value per share of Rs 43.6, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.79x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.14x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">59.37x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.73x to 1,399.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.42x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">27.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.23%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.65%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.03%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 243.99 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 790.89 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,695.63 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Accretion Nutraveda (ANL) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Accretion Nutraveda (ANL) has a P\/E ratio of 48.14x, which is above the benchmark median of 30.79x, a difference of +56.35%. The P\/E comparison frames valuation; it is not a signal to buy or sell.<\/p>\n<p>Accretion Nutraveda (ANL) has a ROE of 27.68%, which is above the benchmark median of 11.23%, a difference of +146.48%. Accretion Nutraveda (ANL) has a ROCE of 30.19%, which is above the benchmark median of 13.1%, a difference of +130.46%.<\/p>\n<p>Track stocks among today&#39;s decliners through the <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,49,227.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">41.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,93,873.72<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">88.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,76,412.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">82.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lauruslabs\/laurus-labs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Laurus Labs<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">LAURUSLABS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,25,460.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">92.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,201.71<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Accretion Nutraveda (ANL) has a P\/E ratio of 48.14x compared with the displayed peer median of 82.66x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 27.68% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 30.19% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Accretion Nutraveda (ANL) has a market capitalisation of Rs 243.99 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Accretion_Nutraveda\"><\/span><strong>Why Investors Are Watching Accretion Nutraveda<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Accretion Nutraveda Share Price fell 12.11% to Rs 296.20, making the latest session the main market event.<\/li>\n<li>The stock remains in the Micro Cap category with market capitalisation of Rs 243.99 crore.<\/li>\n<li>P\/E of 48.14 and P\/B of 7.73 keep valuation central to Accretion Nutraveda Share Price analysis.<\/li>\n<li>ROE of 27.68% and ROCE of 30.19% are higher than the industry medians in the healthcare benchmark.<\/li>\n<li>EPS of Rs 7, book value of Rs 43.6 and dividend yield of 0.00% give investors a compact fundamental snapshot.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Accretion_Nutraveda\"><\/span><strong>About Accretion Nutraveda<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Accretion Nutraveda operates in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. The available figures point to a listed company with a Micro Cap market profile and a business tracked by valuation, return and earnings metrics. Accretion Nutraveda Share Price is therefore best understood in the context of a healthcare name where investors are comparing current price, earnings power, book value and capital returns. The stock\u2019s exact business mix, product split and segment revenue contribution are not provided here, so the clearest verified view is that it belongs to the pharmaceuticals and drugs space and is analysed alongside the wider healthcare benchmark.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Accretion_Nutraveda_Share_Price_on_Univest\"><\/span><strong>Track Accretion Nutraveda Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/anl\/accretion-nutraveda-ltd-share-price-today\">Accretion Nutraveda (ANL) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>You can follow Accretion Nutraveda Share Price on Univest for live share price updates, key fundamental ratios, 52-week levels and broader market insights in one place. Univest also keeps the latest company context, peer comparison and sector view together, which helps readers review Accretion Nutraveda Share Price without searching across multiple screens.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Accretion_Nutraveda_Share_Price_fall_today\"><\/span><strong>Why did Accretion Nutraveda Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Accretion Nutraveda Share Price fell 12.11% to Rs 296.20 from Rs 337. According to Univest data, the price event is confirmed, but no company-specific catalyst is established from the available figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Accretion_Nutraveda_Share_Price_today\"><\/span><strong>What is Accretion Nutraveda Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Accretion Nutraveda Share Price today is Rs 296.20. The move is down Rs 40.80, and the stock\u2019s day open, high and low are all at the same level in the current update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Accretion_Nutraveda_market_capitalisation\"><\/span><strong>What is Accretion Nutraveda market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Accretion Nutraveda has a market capitalisation of Rs 243.99 crore. That places it in the Micro Cap category and helps frame the stock\u2019s price move within a smaller company-size context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Accretion_Nutraveda_Share_Price_compare_with_the_healthcare_benchmark\"><\/span><strong>How does Accretion Nutraveda Share Price compare with the healthcare benchmark?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Accretion Nutraveda Share Price trades at a P\/E of 48.14 versus the industry median of 30.79 and a P\/B of 7.73 versus 2.85. Its ROE and ROCE are also above benchmark medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Accretion_Nutraveda_Share_Price_expensive_versus_peers\"><\/span><strong>Is Accretion Nutraveda Share Price expensive versus peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Accretion Nutraveda Share Price sits above Zydus Lifesciences and Sun Pharma on P\/E, but below Divi&#39;s Laboratories, Torrent Pharmaceuticals and Laurus Labs. The stock also has a much smaller market cap than every listed peer shown.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_EPS_and_book_value_mean_for_Accretion_Nutraveda_Share_Price\"><\/span><strong>What do EPS and book value mean for Accretion Nutraveda Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;EPS is Rs 7 and book value is Rs 43.6. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share in the latest figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_Accretion_Nutraveda_pay_a_dividend\"><\/span><strong>Does Accretion Nutraveda pay a dividend?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;The dividend yield is 0.00%, so no current dividend yield is reflected in the latest Univest figures. Accretion Nutraveda Share Price should therefore be read more through valuation and return metrics than income yield.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_return_ratios_for_Accretion_Nutraveda\"><\/span><strong>What are the key return ratios for Accretion Nutraveda?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Accretion Nutraveda reports ROE of 27.68% and ROCE of 30.19%. Those figures are both above the benchmark medians for the same industry, which gives important context for Accretion Nutraveda Share Price analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_watch_next_in_Accretion_Nutraveda_Share_Price\"><\/span><strong>What should investors watch next in Accretion Nutraveda Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;Investors should watch whether Accretion Nutraveda Share Price holds near Rs 296.20 and whether the market continues to weigh its high P\/E and P\/B against strong ROE and ROCE. Univest will keep the update central.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why did Accretion Nutraveda Share Price fall today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Accretion Nutraveda Share Price fell 12.11% to Rs 296.20 from Rs 337. According to Univest data, the price event is confirmed, but no company-specific catalyst is established from the available figures.\"}},{\"@type\":\"Question\",\"name\":\"What is Accretion Nutraveda Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Accretion Nutraveda Share Price today is Rs 296.20. The move is down Rs 40.80, and the stock\u2019s day open, high and low are all at the same level in the current update.\"}},{\"@type\":\"Question\",\"name\":\"What is Accretion Nutraveda market capitalisation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Accretion Nutraveda has a market capitalisation of Rs 243.99 crore. That places it in the Micro Cap category and helps frame the stock\u2019s price move within a smaller company-size context.\"}},{\"@type\":\"Question\",\"name\":\"How does Accretion Nutraveda Share Price compare with the healthcare benchmark?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Accretion Nutraveda Share Price trades at a P\/E of 48.14 versus the industry median of 30.79 and a P\/B of 7.73 versus 2.85. Its ROE and ROCE are also above benchmark medians.\"}},{\"@type\":\"Question\",\"name\":\"Is Accretion Nutraveda Share Price expensive versus peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Accretion Nutraveda Share Price sits above Zydus Lifesciences and Sun Pharma on P\/E, but below Divi's Laboratories, Torrent Pharmaceuticals and Laurus Labs. The stock also has a much smaller market cap than every listed peer shown.\"}},{\"@type\":\"Question\",\"name\":\"What do EPS and book value mean for Accretion Nutraveda Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"EPS is Rs 7 and book value is Rs 43.6. EPS shows earnings attributable to each share, while book value per share shows the accounting net worth behind each share in the latest figures.\"}},{\"@type\":\"Question\",\"name\":\"Does Accretion Nutraveda pay a dividend?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The dividend yield is 0.00%, so no current dividend yield is reflected in the latest Univest figures. Accretion Nutraveda Share Price should therefore be read more through valuation and return metrics than income yield.\"}},{\"@type\":\"Question\",\"name\":\"What are the key return ratios for Accretion Nutraveda?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Accretion Nutraveda reports ROE of 27.68% and ROCE of 30.19%. Those figures are both above the benchmark medians for the same industry, which gives important context for Accretion Nutraveda Share Price analysis.\"}},{\"@type\":\"Question\",\"name\":\"What should investors watch next in Accretion Nutraveda Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should watch whether Accretion Nutraveda Share Price holds near Rs 296.20 and whether the market continues to weigh its high P\/E and P\/B against strong ROE and ROCE. Univest will keep the update central.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Accretion Nutraveda Share Price fell 12.11% to Rs 296.20 today. Market cap stands at Rs 243.99 crore.<\/p>\n","protected":false},"author":35,"featured_media":356986,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-356987","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["356986"],"rank_math_title":["Accretion Nutraveda Share Price Today: Sharp 12.11% Drop"],"rank_math_description":["Accretion Nutraveda Share Price fell 12.11% to Rs 296.20. See price action, valuation, ROE, ROCE, EPS and healthcare peer context."],"rank_math_focus_keyword":["Accretion Nutraveda Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Accretion_Nutraveda_ANL_Share_Price_Falls_1211_in_Latest_Session_bearish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/356987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=356987"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/356987\/revisions"}],"predecessor-version":[{"id":356988,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/356987\/revisions\/356988"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/356986"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=356987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=356987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=356987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}